Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

NRXS Neuraxis Inc

0.13 (4.29%)
2024年5月25日 - 終了
名称 銘柄コード 市場 種別
Neuraxis Inc NRXS AMEX 普通株式
  前日比 前日比 % 現在値 時刻
0.13 4.29% 3.16 07:30:09
始値 安値 高値 終値 前日終値
3.15 2.99 3.26 3.16 3.03
この銘柄の詳細情報 »


日付 時間 ソース タイトル
2024/5/2221:00GLOBENeurAxis Reports First Quarter 2024 Financial Results
2024/5/2122:00GLOBENeurAxis to Participate in the Lytham Partners Spring 2024..
2024/5/2105:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/1622:00GLOBENeurAxis Announces New Medical Policy Coverage For Nearly..
2024/5/1605:30GLOBENeurAxis to Host First Quarter 2024 Results and Business..
2024/5/1605:15EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
2024/4/2322:00GLOBENeurAxis Announces New Medical Policy Coverage in North..
2024/4/1005:05GLOBENeurAxis Reports Fourth Quarter and Fiscal Year 2023..
2024/4/0205:15GLOBENeurAxis to Host Fourth Quarter and Full Year 2023 Results..
2024/3/2722:00GLOBENeurAxis Announces IB-Stim Results from a Large, Pediatric,..
2024/3/1122:00GLOBENeurAxis Announces Highmark BCBS Policy Coverage
2024/3/1121:50EDGAR2Form 8-K - Current report
2024/3/0423:00GLOBENeurAxis Announces Blue Cross and Blue Shield of Kansas City..
2024/2/2801:00GLOBENeurAxis to Present at Oppenheimer 34th Annual Healthcare..
2024/2/1607:00EDGAR2Form 8-K - Current report
2024/1/3123:15EDGAR2Form 8-K - Current report
2023/12/2023:00GLOBENeurAxis, Inc. Issues Letter to Shareholders from Brian..
2023/12/2007:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/12/2007:00EDGAR2Form 8-K - Current report
2023/11/2107:30GLOBENeurAxis Reports Third Quarter 2023 Financial Results
2023/11/2107:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1523:00GLOBENeurAxis Announces CareFirst BCBS Policy Coverage
2023/11/1423:00GLOBENeurAxis Secures $3 Million Financing
2023/11/0823:00GLOBENeurAxis Signs Exclusive Option Agreement with University of..
2023/9/2622:00GLOBENeurAxis Announces Results of Comparative Study of IB-Stim™..
2023/9/2305:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/9/2121:30EDGAR2Form 8-K - Current report
2023/9/2121:00GLOBENeurAxis Reports Second Quarter 2023 Financial Results
2023/9/1405:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/9/1322:00GLOBENeurAxis to Present at the Gilmartin Group Emerging Growth..
2023/9/1222:00GLOBENeurAxis Announces Publication of Prospective Study Showing..
2023/8/3000:49APSNews Brief: NeurAxis Inc.
2023/8/2922:00GLOBENeurAxis Highlights Pediatric Post-Concussion Clinical Study
2023/8/2422:00GLOBENeurAxis Highlights Strength of its Board of Directors
2023/8/2222:00GLOBENeurAxis Highlights Two Independent Studies Showing Benefits..
2023/8/1722:02GLOBENeurAxis Announces Over $8 Million in IB-Stim™ Revenue
2023/8/1022:00GLOBEExchange Listing Client, Neuraxis, Inc., Successfully..


Delayed Upgrade Clock